U-Blot® Research Grade AxatilimabCat. No. WA2464$9,999
Size: 50ug/100ug
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade AxatilimabCat. No. WA2464
U-Blot® Research Grade AvizakimabCat. No. WA2463
U-Blot® Research Grade AvitotamigCat. No. WA2462
U-Blot® Research Grade AvelumabCat. No. WA2461
U-Blot® Research Grade AvdoralimabCat. No. WA2460
U-Blot® Research Grade AtrosimabCat. No. WA2459
U-Blot® Research Grade AtorolimumabCat. No. WA2458
U-Blot® Research Grade AtoltivimabCat. No. WA2457
U-Blot® Research Grade AtisnolerbartCat. No. WA2456
U-Blot® Research Grade AtinumabCat. No. WA2455
U-Blot® Research Grade AtigotatugCat. No. WA2454
U-Blot® Research Grade AtidortoxumabCat. No. WA2453